The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer

Objective: The authors monitored positivity rates of asymptomatic SARS-CoV-2 tests during the second wave of COVID-19 at Guy's Cancer Centre. Methods: Logistic regression was used to investigate factors associated with asymptomatic COVID positivity rates between 1 December 2020 and 28 February 2021 (n = 1346). Results: Living 20–40 km and 40–60 km from the alpha variant was associated with a reduced chance of a positive SARS-CoV-2 test compared with 0–20 km (odds ratio [OR]: 0.20; CI: 0.07–0.53 and OR: 0.38; CI: 0.15–0.98, respectively). An increased number of tests was associated with an increased chance of a positive SARS-CoV-2 test (OR: 1.10; CI: 1.04–1.16). Conclusion: The COVID-19 positivity rate of asymptomatic cancer patients is partly due to increased testing, with some contribution from the proximity of the patient population to the epicenter of the alpha variant.

[1]  A. Dell'Acqua,et al.  Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan , 2021, Cancers.

[2]  D. Josephs,et al.  Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre , 2021, Poster Presentations - Proffered Abstracts.

[3]  A. Purushotham,et al.  The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients , 2021, Ecancermedicalscience.

[4]  T. Roques,et al.  The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study , 2021, The Lancet Oncology.

[5]  M. Landray,et al.  Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study , 2021, The Lancet Gastroenterology & Hepatology.

[6]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[7]  A. Hayward,et al.  A rapid review and meta-analysis of the asymptomatic proportion of PCR-confirmed SARS-CoV-2 infections in community settings , 2020, Wellcome Open Research.

[8]  Jiming Zhang,et al.  Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[9]  H. Kourie,et al.  Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities , 2020, Future oncology.

[10]  Investigation of novel SARS-COV-2 variant Variant of Concern 202012/01 , 2020 .

[11]  J. Hall Early detection and diagnosis of cancer , 1962 .